Literature DB >> 20740538

Mass spectrometric characterization of gelsolin isoforms.

G Pottiez1, N Haverland, P Ciborowski.   

Abstract

Gelsolin is the most widely expressed member of the actin capping and severing family of proteins. There are two isoforms of gelsolin: isoform 1, a secretory (plasma) protein that is 51 amino acids longer than isoform 2, a cytosolic protein, at the N-terminus; the first 27 amino acids is a signal sequence. Both isoforms are coded by a single gene and differ as a result of alternative initiation site/splicing. The level of gelsolin in the blood and cerebrospinal fluid (CSF) is altered in many diseases including amyloidoses and other neurodegenerative disorders. Although quantitative analysis of gelsolin has been reported, lack of suitable antibodies makes it impossible to differentiate these two isoforms by immunodetection techniques and no other technique is available. Therefore, ambiguity exists whether gelsolin present in circulation is isoform 1 or also isoform 2 released from lysed cells. We report in this communication a mass spectrometric approach to identify isoform 1 of gelsolin immunopurified from human plasma and CSF. Recombinant isoform 1 was used as reference. Copyright 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20740538      PMCID: PMC3286873          DOI: 10.1002/rcm.4681

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  23 in total

1.  Proteomics analysis of phosphotyrosyl-proteins in human lumbar cerebrospinal fluid.

Authors:  Xianglin Yuan; Dominic M Desiderio
Journal:  J Proteome Res       Date:  2003 Sep-Oct       Impact factor: 4.466

2.  Identification of Tyr438 as the major in vitro c-Src phosphorylation site in human gelsolin: a mass spectrometric approach.

Authors:  V De Corte; H Demol; M Goethals; J Van Damme; J Gettemans; J Vandekerckhove
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

3.  Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis.

Authors:  E Suhler; W Lin; H L Yin; W M Lee
Journal:  Crit Care Med       Date:  1997-04       Impact factor: 7.598

4.  Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain.

Authors:  D J Kwiatkowski; T P Stossel; S H Orkin; J E Mole; H R Colten; H L Yin
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

5.  Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin.

Authors:  H L Yin; D J Kwiatkowski; J E Mole; F S Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

6.  Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment.

Authors:  Wojciech Rozek; Mary Ricardo-Dukelow; Sondra Holloway; Howard E Gendelman; Valerie Wojna; Loyda M Melendez; Pawel Ciborowski
Journal:  J Proteome Res       Date:  2007-10-12       Impact factor: 4.466

7.  Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis.

Authors:  T Paunio; H Kangas; O Heinonen; M H Buc-Caron; J J Robert; S Kaasinen; I Julkunen; J Mallet; L Peltonen
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

8.  Identification of secreted and cytosolic gelsolin in Drosophila.

Authors:  M C Stella; H Schauerte; K L Straub; M Leptin
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

9.  Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis.

Authors:  Teresia M Osborn; Margareta Verdrengh; Thomas P Stossel; Andrej Tarkowski; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2008-09-27       Impact factor: 5.156

10.  Biomarkers of HIV-1 associated dementia: proteomic investigation of sera.

Authors:  Jayme Wiederin; Wojciech Rozek; Fenghai Duan; Pawel Ciborowski
Journal:  Proteome Sci       Date:  2009-03-17       Impact factor: 2.480

View more
  8 in total

1.  Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques.

Authors:  T Jagadish; G Pottiez; H S Fox; P Ciborowski
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

2.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

3.  Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1.

Authors:  Han Liu; Jianuo Liu; Shangdong Liang; Huangui Xiong
Journal:  Mol Cell Neurosci       Date:  2013-11       Impact factor: 4.314

Review 4.  Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?

Authors:  Joachim Voss; Young Ah Goo; Kevin Cain; Nancy Woods; Monica Jarrett; Lynne Smith; Robert Shulman; Margaret Heitkemper
Journal:  Biol Res Nurs       Date:  2011-05-17       Impact factor: 2.522

5.  Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

Authors:  Nicole Haverland; Gwënaël Pottiez; Jayme Wiederin; Pawel Ciborowski
Journal:  J Transl Med       Date:  2010-12-20       Impact factor: 5.531

6.  Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients.

Authors:  Li-feng Huang; Yong-ming Yao; Jin-feng Li; Ning Dong; Chen Liu; Yan Yu; Li-xin He; Zhi-yong Sheng
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

7.  A cell model for conditional profiling of androgen-receptor-interacting proteins.

Authors:  K A Mooslehner; J D Davies; I A Hughes
Journal:  Int J Endocrinol       Date:  2012-02-27       Impact factor: 3.257

Review 8.  HIV and Proteomics: What We Have Learned from High Throughput Studies.

Authors:  Kinga Grabowska; Emma Harwood; Pawel Ciborowski
Journal:  Proteomics Clin Appl       Date:  2020-10-14       Impact factor: 3.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.